SCHEMBL6817670

SCHEMBL6817670

C=C1/C(=C/CO)C[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@H]1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8071841 1.00 STAT3 (0.30) STAT3
SCHEMBL8071839 1.00 STAT3 (0.30) STAT3
SCHEMBL8071840 1.00 STAT3 (0.30) STAT3
SCHEMBL20243249 1.00 STAT3 (0.30) STAT3
SCHEMBL7146669 1.00 STAT3 (0.30) STAT3
SCHEMBL8077670 1.00 STAT3 (0.30) STAT3
SCHEMBL20243244 0.88
SCHEMBL13853996 0.87
SCHEMBL2528390 0.87
SCHEMBL8079278 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1200399-B1 VITAMIN D3 ANALOGS HOFFMANN LA ROCHE (CH) 2004-03-24 EP disclosed
US-6331642-B1 Vitamin D3 analogs HOFFMANN-LA ROCHE INC. 2001-12-18 US disclosed
US-6043385-A TREATMENT OF PSORIASIS, BASAL CELL CARCINOMAS, DISORDERS OF KERATINIZATION AND KERATOSIS, NEOPLASTIC DISEASES SUCH AS LEUKEMIA, DISORDERS OF THE SEBACEOUS GLANDS SUCH AS ACNE AND SEBORRHOIC DERMATITIS, OSTEOPOROSIS, HYPERPARATHYROIDISM HOFFMAN-LA ROCHE INC. (US) 2000-03-28 US disclosed